CLINICAL_TRIALS trial_result · 2025-02-24

Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment [Phase 4]

Phase 4 trial evaluating VEGF level changes in retinal vein occlusion patients during anti-VEGF therapy has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Wake Forest University Health Sciences | Conditions: Retinal Vein Occlusion | Phase 4 | Status: TERMINATED | Results posted: 2025-02-24